Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | NQO1 | P15559 | 1/20 | 0.52 |
| ▸ | ACACB | O00763 | 14/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.45 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2056242 | 0.90 | L3MBTL1 (0.67) | L3MBTL1NQO1MAOBAOC3CACNA2D1 | |
| SCHEMBL9816286 | 0.87 | ACACB (0.52) | L3MBTL1NQO1ACACBCACNA2D1 | |
| SCHEMBL28659226 | 0.86 | ACACB (0.50) | L3MBTL1ACACBMAOBAOC3TSHR | |
| SCHEMBL9512274 | 0.86 | ACACB (0.50) | L3MBTL1ACACBMAOBAOC3 | |
| SCHEMBL9509479 | 0.86 | ACACB (0.47) | L3MBTL1ACACBMAOBAOC3TSHR | |
| SCHEMBL9509352 | 0.85 | ACACB (0.56) | L3MBTL1ACACBMAOBAOC3TSHR | |
| SCHEMBL31160399 | 0.84 | NQO1 (0.74) | NQO1ACACBTSHRTDP1 | |
| SCHEMBL9511484 | 0.83 | NR5A1 (0.49) | L3MBTL1ACACBTSHR | |
| SCHEMBL9156035 | 0.82 | ACACB (0.45) | L3MBTL1NQO1ACACB | |
| SCHEMBL9510195 | 0.82 | NR5A1 (0.51) | L3MBTL1ACACBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0308438-B1 | LIQUID CRYSTAL PHASE CONTAINING TOLANES | MERCK PATENT GmbH (DE) | 1993-09-29 | — | — | EP | claimed |